The discovery of novel, potent and selective PDE5 inhibitors

Yingzhi Bi(Bristol-Myers Squibb (Germany)), John E. Macor(Bristol-Myers Squibb (United States)), Leonard P. Adam(Bristol-Myers Squibb (United States)), Diane E. Normandin(Bristol-Myers Squibb (United States)), Ron Pongrac(Bristol-Myers Squibb (United States)), Bin He(Guiyang Medical University), John Krupinski(Bristol-Myers Squibb (United States)), Andrew J. Watson(McCormick Theological Seminary), Laurie Seliger(Bristol-Myers Squibb (United States)), Patrick Stoy(Bristol-Myers Squibb (United States))
Bioorganic & Medicinal Chemistry Letters
September 1, 2001
10.1016/s0960-894x(01)00466-8
Cited by 30

Related Papers

Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k
SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine
|Nature|2013|706
Overview of lethal human coronaviruses
|Signal Transduction and Targeted Therapy|2020|312
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
|Acta Neuropathologica Communications|2017|306
Identification of a cellularly active SIRT6 allosteric activator
|Nature Chemical Biology|2018|272